Anemia May Not Weaken Benefit of Ruxolitinib for Myelofibrosis
Liso-cel Potentially More Effective in Earlier Lines of Treatment for MCL
Lower Basal Inflammation, Tumor Burden Linked to PFS Improvements With Ide-Cel in Myeloma
Helping Patients Navigate a New Diagnosis of CML